LC
AZN icon

Lavaca Capital’s AstraZeneca AZN Stock Holding History

Lavaca Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Buy
1,648
+1,548
+1,548% +$291K 0.03% 106
2026
Q1 		$19.7K Sell
100
-1,771
-95% -$341K ﹤0.01% 219
2025
Q4 		$344K Hold
1,871
– – 0.06% 76
2025
Q3 		$287K Hold
1,871
– – 0.05% 86
2025
Q2 		$261K Buy
+1,871
New +$262K 0.1% 93

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lavaca Capital's AZN Position: Q2 2026 in Review

Lavaca Capital increased its AstraZeneca (AZN) stake by 1,548% in Q2 2026, buying an estimated $291K and bringing the position to 1,648 shares worth $312K. The position accounts for 0.03% of the portfolio, ranked #106.

Lavaca Capital first reported a position in AZN in Q2 2025 and has held it in 5 quarters since. The position peaked at $344K in Q4 2025. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Lavaca Capital held 1,648 shares of AstraZeneca worth $312K as of Q2 2026.
  • Lavaca Capital bought 1,548 AstraZeneca shares in Q2 2026, an estimated $291K.
  • AstraZeneca made up 0.03% of Lavaca Capital's portfolio in Q2 2026, its #106 holding.
  • Lavaca Capital first reported a position in AstraZeneca in Q2 2025 and has held it in 5 quarters since.
  • Lavaca Capital's AstraZeneca position peaked at $344K in Q4 2025.
  • 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Lavaca Capital's 13F filing for Q2 2026, filed 14 Aug 2026.